Neuheit Pharma Profile
Key Indicators
- Authorised Capital ₹ 24.10 Cr
as on 04-07-2024
- Paid Up Capital ₹ 23.10 Cr
as on 04-07-2024
- Company Age 9 Year, 7 Months
- Last Filing with ROC 31 Mar 2020
- Satisfied Charges ₹ 12.50 Cr
as on 04-07-2024
- Revenue 935.28%
(FY 2020)
- Profit -18020.04%
(FY 2020)
- Ebitda -5490.88%
(FY 2020)
- Net Worth -31.73%
(FY 2020)
- Total Assets -13.86%
(FY 2020)
About Neuheit Pharma
- CIN/LLPIN
U24233TG2015PTC098047
- Company No.
098047
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Mar 2015
- Date of AGM
02 Dec 2020
- Date of Balance Sheet
31 Mar 2020
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Kukatpally, Telangana, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Neuheit Pharma?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Srinivas Irukulla  | Managing Director | 16-Mar-2015 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Venkateswarlu Vobalaboina | Director | 16-Mar-2015 | Current |
Siddhartha Bhoopathy  | Director | 10-Aug-2017 | Current |
| Patrick Dentinger | Director | 10-Aug-2017 | Current |
Financial Performance and Corporate Structure Insights of Neuheit Pharma.
Neuheit Pharma Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 935.28% increase. The company also saw a substantial fall in profitability, with a 18020.04% decrease in profit. The company's net worth observed a substantial decline by a decrease of 31.73%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Neuheit Pharma?
In 2020, Neuheit Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Neuheit Pharma Technologies Private Limited
Active 11 years 2 monthsVenkateswarlu Vobalaboina is a mutual person
Concresco Pharma Technologies Private Limited
Active 1 year 2 monthsSrinivas Irukulla is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 22 Nov 2018 | ₹12.50 Cr | Satisfied |
How Many Employees Work at Neuheit Pharma?
Unlock and access historical data on people associated with Neuheit Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Neuheit Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Neuheit Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
